lk_exposure_material

NameDescriptionLinkID
exposure_material_preferred ; exposure_material_id
2008-2009 trivalent influenza vaccine ; VO:0004809 2008-2009 trivalent influenza vaccine
2011-2012 trivalent inactivated vaccine (A/California/7/09 (H1N1), A/Perth /16/2009 (H3N2), and B/Brisbane/60/2008) ; VO:0004810 2011-2012 trivalent inactivated vaccine (A/California/7/09 (H1N1), A/Perth /16/2009 (H3N2), and B/Brisbane/60/2008)
ACWY Vax ; VO:0003138 ACWY Vax
Ad35.CS.01 malaria vaccine ; VO:0004993 A P. falciparum malaria vaccine that is formed by tull length CS-expressing replication-deficient recombinant human adenovirus 35.
AdCOVID ; VO_0005153 AdCOVID
Alternaria alternata ; NCBITaxon:5599 species, ascomycetes
BCG Vaccine ; VO:0000771 BCG Vaccine is a Mycobacterium tuberculosis vaccine that is a live attenuated strain of Mycobacterium bovis (Bacillus Calmette Guerin; BCG).
Borreliella burgdorferi ; NCBITaxon:139 Borreliella burgdorferi
Chikungunya virus ; NCBITaxon:37124 Found from reported data using NCBI Taxomony Dump: 37124
Chlamydia trachomatis ; NCBITaxon:813 Chlamydia trachomatis
CureVac AG ; VO:0005208 CureVac AG
Cytomegalovirus ; NCBITaxon:10358 Cytomegalovirus
Dengue virus 1 ; NCBITaxon:11053 Dengue virus 1
Dengue virus 2 ; NCBITaxon:11060 Dengue virus 2
Dengue virus 3 ; NCBITaxon:11069 Found from reported data using NCBI Taxomony Dump: 11069
Dengue virus ; NCBITaxon:12637 Dengue virus
diphtheria, tetanus and whole cell pertussis vaccine ; VO:0003106 diphtheria, tetanus and whole cell pertussis vaccine
Diphtheria-Tetanus-Pertussis vaccine ; VO:0000738 Diphtheria-Tetanus-Pertussis vaccine
Dryvax ; VO:0000035 a vaccinia virus vaccine that is a freeze-dried calf lymph smallpox vaccine, specifically, Dryvax is a live-virus preparation of vaccinia prepared from calf lymph.
Engerix-B ; VO:0010711 Engerix-B
Fluarix ; VO:0000045 Fluarix
FluMist ; VO:0000044 FluMist
Fluvirin ; VO:0000046 Fluvirin
Fluzone ; VO:0000047 Fluzone
Hepacivirus C ; NCBITaxon:11103 Found from reported data using NCBI Taxomony Dump: 11103
Hepatitis B surface antigen vaccine ; VO_0003150 A Hepatitis B virus vaccine that uses recombinant Hepatitis B surface antigen as the antigen
Hepatitis B Surface Antigen Vaccine Injection [Heplisav-B] ; VO_0003270 Hepatitis B Surface Antigen Vaccine Injection [Heplisav-B]
Hepatitis B Surface Antigen Vaccine Prefilled Syringe [Engerix-B] ; VO_0003258 Hepatitis B Surface Antigen Vaccine Prefilled Syringe [Engerix-B]
Hepatitis B virus ; NCBITaxon:10407 Hepatitis B virus
Hepatitis B virus vaccine ; VO_0000644 A viral vaccine that protects against infection with Hepatitis B virus.
HEPLISAV-B ; VO:0003152 A Hepatitis B surface antigen viral vaccine that utilizes a cytidine-phosphate-guanosine oligodeoxynucleotide (CpGODN) 1018, as an adjuvant.
Human alphaherpesvirus 3 ; NCBITaxon:10335 Human alphaherpesvirus 3
Human gammaherpesvirus 4 (Epstein-Barr virus) ; NCBITaxon:10376 Human gammaherpesvirus 4 (Epstein-Barr virus)
human immunodeficiency virus infectious disease ; DOID:526 A viral infectious disease that results in destruction of immune system, leading to life-threatening opportunistic infections and cancers, has_material_basis_in Human immunodeficiency virus 1 or has_material_basis_in Human immunodeficiency virus 2, which are transmitted by sexual contact, transmitted by transfer of blood, semen, vaginal fluid, pre-ejaculate, or breast milk, transmitted by congenital method, and transmitted by contaminated needles. The virus infects helper T cells (CD4+ T cells) which are directly or indirectly destroyed, macrophages, and dendritic cells. The infection has symptom diarrhea, has symptom fatigue, has symptom fever, has symptom vaginal yeast infection, has symptom headache, has symptom mouth sores, has symptom muscle aches, has symptom sore throat, and has symptom swollen lymph glands.
human immunodeficiency virus vaccine ; VO_0000295 A viral vaccine that protects against infection with human immunodeficiency virus that causes AIDS.
Human rhinovirus A16 ; NCBITaxon:31708 Found from reported data using NCBI Taxomony Dump: 31708
inactivated influenza vaccine ; VO_0001176 inactivated influenza vaccine is an inactivated viral vaccine that targets at influenza viral infections.
Influenza A H1N1 2009 Monovalent Vaccine Novartis ; VO:0000081 Influenza A (H1N1) 2009 Monovalent Vaccine (Novartis)
Influenza A virus (A/California/7/2009(H1N1)) ; NCBITaxon:1316510 Found from reported data using NCBI Taxomony Dump: 1316510
Influenza A virus (A/reassortant/FluMist(California/07/2009 x Ann Arbor/6/1960)(H1N1)) ; NCBITaxon:1701435 Found from reported data using NCBI Taxomony Dump: 1701435
Influenza A virus ; NCBITaxon:11320 Influenza A virus
Influenza virus vaccine ; VO:0000642 A viral vaccine that protects against infection with influenza virus.
Influvac ; VO_0000867 Influvac is an Influenza virus vaccine that is manufactured by Solvay Pharma.
Ionizing Radiation ; NCIT:C17052 High-energy radiation capable of producing ionization in substances through which it passes.
Johnson & Johnson COVID-19 vaccine ; VO:0005159 A SARS-CoV-2 recombinant viral vector vaccine composed of Ad26 vector expressing S protein, Ad26COVS1; JNJ-78436735
LC16m8 ; VO:0004091 LC16m8
live attenuated influenza vaccine ; VO_0001178 live attenuated influenza vaccine is a live attenuated vaccine that protects against influenza viral infection.
Menactra ; VO:0000071 Menactra
Meningococcal Polysaccharide Vaccine, Groups A & C, Menomune A/C ; VO:0010725 Meningococcal Polysaccharide Vaccine, Groups A & C, Menomune A/C
Menveo ; VO:0001246 Menveo
Moderna COVID-19 vaccine ; VO:0005157 A SARS-CoV2 RNA vaccine made of lipid nanoparticle with mRNA which encodes the S-2P antigen, made of the SARS-CoV-2 glycoprotein with a transmembrane anchor and intact S1-S2 cleavage site
MRKAd5 HIV-1 gag/pol/nef ; VO:0003133 The MRK adenovirus type 5 human immunodeficiency virus type 1 clade B gag/pol/nef vaccine is a replication-incompetent adenovirus type 5-vectored vaccine that elicits cell-mediated immunity against conserved human immunodeficiency virus proteins.
MVA85A ; VO:0003120 MVA85A
Mycobacterium tuberculosis ; NCBITaxon:1773 Mycobacterium tuberculosis
NVX-CoV2373 ; VO:0005155 A SARS-CoV 2 (rSARS-CoV-2) subunit vaccine made of nanoparticles composed of a trimeric full-length SARS-CoV-2 spike glycoprotein and Matrix-M1 adjuvant
Other ; Other Other
Oxford AstraZeneca COVID-19 vaccine ; VO:0005158 A SARS-CoV2 recombinat vector vaccine made of a chimpanzee adenovirus-vectored vaccine expressing the SARS-CoV-2 spike protein
P. falciparum RTS,S/AS01 ; VO:0003093 A malaria vaccine that consists of hepatitis B surface antigen virus-like particles, incorporating a portion of the Plasmodium falciparum-derived circumsporozoite protein and a liposome-based adjuvant.
Pfizer BioNTech COVID-19 vaccine ; VO:0004987 A SARS-CoV-2 RNA vaccine formed from a lipid nanoparticle-formulated trimerized SARS-CoV-2 receptor-binding domain
PfSPZ Vaccine ; VO:0004910 a malaria vaccine that protects against malaria caused by Plasmodium falciparum
PfSPZ-CVac ; VO:0004911 a malaria vaccine that protects against malaria caused by Plasmodium falciparum
PfSPZ-GA1 ; VO:0004912 a malaria vaccine that protects against malaria caused by Plasmodium falciparum
Plasmodium coatneyi ; NCBITaxon:208452 Found from reported data using NCBI Taxomony Dump: 208452
Plasmodium cynomolgi strain B ; NCBITaxon:1120755 Found from reported data using NCBI Taxomony Dump: 1120755
Plasmodium cynomolgi strain Ceylon ; NCBITaxon:5829 Found from reported data using NCBI Taxomony Dump: 5829
Plasmodium falciparum ; NCBITaxon:5833 malaria parasite P. falciparum
Plasmodium falciparum vaccine ; VO:0000087 a malaria vaccine that protects against malaria caused by Plasmodium falciparum.
Plasmodium vivax ; NCBITaxon:5855 Found from reported data using NCBI Taxomony Dump: 5855
Pneumovax 23 ; VO:0000088 Pneumovax 23
quadrivalent inactivated influenza vaccine ; VO_0010196 quadrivalent inactivated influenza vaccine
Respiratory syncytial virus ; NCBITaxon:12814 Respiratory syncytial (sin-SISH-uhl) virus, or RSV, is a common respiratory virus that usually causes mild, cold-like symptoms. Most people recover in a week or two, but RSV can be serious, especially for infants and older adults.
rVSV-EBOV ; VO:0004660 An Ebola virus vaccine that uses a recombinant vesicular stomatitis virus (rVSV) vector expressing an Ebola filovirus glycoprotein
SARS Coronavirus 2 B.1.1.529 ; UMLS_CUI:C5564753 WHO Name: Omicron. A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletions of the amino acids at positions 69/70, 143/145 and 212 and amino acid substitutions A67V, T95I, G142D, N211I, G339D, S371L, S373P, S375F, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, D796Y, N856K, Q954H, N969K and L981F. (NCI)
SARS Coronavirus 2 BA.1 ; UMLS_CUI:C5706968 WHO Name: Omicron. A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletions of the amino acids at positions 69/70, 143/145 and 212 and amino acid substitutions A67V, T95I, G142D, N211I, G339D, S371L, S373P, S375F, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y, N679K, P681H, N764K, D796Y, N856K, Q954H, N969K and L981F. (NCI).
SARS Coronavirus 2 BA.2 ; UMLS_CUI:C5670041 WHO Name: Omicron. A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletions of the amino acids at positions 25/27 and amino acid substitutions T19I, L24S, G142D, V213G, G339D, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, S477N, T478K, E484A, Q493R, Q498R, N501Y, Y505H, D614G, H655Y, N679K, P681H, N764K, D796Y, Q954H and N969K. (NCI)
SARS Coronavirus 2 BA.3 ; UMLS_CUI:C5706967 WHO Name: Omicron. A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletions of the amino acids at positions 69/70, 143/145 and 212 and amino acid substitutions A67V, G142D, N211I, D614G, H655Y, N679K, P681H, N764K, D796Y, Q954H and N969K. (NCI)
SARS Coronavirus 2 BA.4 ; UMLS_CUI:C5706966 WHO Name: Omicron. A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletions of the amino acids at positions 25/27 and 69/70 and amino acid substitutions T19I, L24S, G142D, V213G, G339D, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, L452R, S477N, T478K, E484A, F486V, Q498R, N501Y, Y505H, D614G, H655Y, N679K, P681H, N764K, D796Y, Q954H and N969K. This variant has two novel amino acid variations, a D61L substitution in the ORF6 protein and a L11F in the ORF7b protein. (NCI)
SARS Coronavirus 2 BA.5 ; UMLS_CUI:C5706965 WHO Name: Omicron. A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletions of the amino acids at positions 25/27 and 69/70 and amino acid substitutions T19I, L24S, G142D, V213G, G339D, S371F, S373P, S375F, T376A, D405N, R408S, K417N, N440K, L452R, S477N, T478K, E484A, F486V, Q498R, N501Y, Y505H, D614G, H655Y, N679K, P681H, N764K, D796Y, Q954H and N969K. (NCI)
SARS Coronavirus 2 C.37 ; UMLS_CUI:C5556619 WHO Name: Lambda. A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletions of the amino acids at positions 247-253 and amino acid substitutions G75V, T76I, L452Q, F490S, D614G and T859N. (NCI)
SARS-CoV-2 ; NCBITaxon:2697049 Severe acute respiratory syndrome coronavirus 2, equivalent: 2019-nCoV
SARS-CoV-2 B.1.1.7 variant ; UMLS_CUI:C5433393 A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletions of the amino acids at positions 69, 70 and 144 and amino acid substitutions N501Y, A570D, D614G, P681H, T716I, S982A and D1118H. The substitutions E484K, S494P and K1191N have also been detected in some but not all sequences for this lineage. (NCI). Also known as B.1.1.7, 20I/501Y.V1, VOC - 202012/01, and UK variant (LNC)
SARS-CoV-2 B.1.351 variant ; UMLS_CUI:C5433395 A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: deletions of the amino acids at positions 241-242 and amino acid substitutions D80A, D215G, K417N, E484K, N501Y, D614G and A701V. (NCI). Also known as B.1.351, 501Y.V2, and South Africa variant (LNC)
SARS-CoV-2 B.1.617.2 lineage ; UMLS_CUI:C5548982 Also known as WHO Delta variant (LNC)
SARS-CoV-2 D614G variant ; UMLS_CUI:C5433391 Known as SARS-CoV-2 USA-WA1/2020. https://www.ncbi.nlm.nih.gov/biosample/SAMN18527778
SARS-CoV-2 Mu variants ; UMLS_CUI:C5564751 A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: an amino acid insertion 146N and amino acid substitutions T95I, Y144T, Y145S, R346K, E484K, N501Y, D614G, P681H and D950N. (NCI). Also known as SARS-CoV-2 B.1.621.
SARS-CoV-2 P.1 variant ; UMLS_CUI:C5433398 A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: amino acid substitutions L18F, T20N, P26S, D138Y, R190S, K417T, E484K, N501Y, D614G, H655Y, T1027I and V1176F. (NCI). Also known as SARS-CoV-2 Gamma; P.1
SARS-CoV-2 P.2 variant ; UMLS_CUI:C5433392 WHO Name: Zeta. A variant lineage of SARS coronavirus 2 where the following variations in the spike glycoprotein sequence have been identified: amino acid substitutions E484K, D614G and V1176F. The substitution F565L has also been detected in some but not all sequences for this lineage. (NCI).
Schistosoma mansoni ; NCBITaxon:6183 Found from reported data using NCBI Taxomony Dump: 6183
Shigella flexneri 2a ; NCBITaxon:42897 Shigella flexneri, serovar 2a. Extended spectrum beta-lactamase producing Shigella flexneri serovar 2a (133131000112102) SNOMEDCT_US
Shigella sonnei ; NCBITaxon:624 A lactose-fermenting bacterium causing dysentery
Sinopharm (BBIBP-CorV) ; VO:0005166 A SARS-CoV-2 inactivated whole virus vaccine that produced in Vero cells that is developed by the Beijing Institute of Biological Products.
Sputnik V ; VO:0005163 A SARS-CoV-2 recombinant viral vector vaccine composed of Ad26 and Ad5 vectors expressing S protein that lyophilised.
Stamaril ; VO:0003139 It is live attenuated YFV vaccine strain 17D manufactured in China, France, Senegal, and the USA. In powder and solvent for suspension for injection in pre-filled syringe.
Staphylococcus aureus ; NCBITaxon:1280 Staphylococcus aureus is a Gram-positive, round-shaped bacterium that is a member of the Firmicutes, and it is a usual member of the microbiota of the body, frequently found in the upper respiratory tract and on the skin.
unidentified ; NCBITaxon:32644 Found from reported data using NCBI Taxomony Dump: 32644
Vaccinia virus LC16M8 ; NCBITaxon:10248 Found from reported data using NCBI Taxomony Dump: 10248
Varicella-zoster virus vaccine ; VO:0000669 a Herpesvirus vaccine that is used against Varicella-zoster virus infection.
West Nile virus ; NCBITaxon:11082 West Nile virus
Yellow fever 17D vaccine vector ; VO:0000122 a viral vaccine vector that uses Yellow fever vaccine strain 17D as the vector.
YF-Vax ; VO:0000121 YF-Vax
Zika virus ; NCBITaxon:64320 Found from reported data using NCBI Taxomony Dump: 64320
Zostavax ; VO:0000124 Zostavax